CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Reckamp, Karen L ^a   Figlin, Robert A ^a   Burdick, Marie D ^b   Dubinett, Steven M ^c   Elashoff, Robert M ^c   Strieter, Robert M ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CYTOKERATIN; CXCR4 PROTEIN, HUMAN; KERATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; METASTASIS POTENTIAL; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; BIOSYNTHESIS; BLOOD; CANCER STAGING; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; TUMOR EMBOLISM;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; KERATINS; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; RECEPTORS, CXCR4;

EID: 67650742534     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-213     Document Type: Article

References (46)

1. Jemal A Siegel R Ward E Murray T Xu J Thun MJ Cancer statistics, 2007 CA Cancer J Clin 2007, 57:43-66. 10.3322/canjclin.57.1.43 17237035
2. Winton T Livingston R Johnson D Rigas J Johnston M Butts C Cormier Y Goss G Inculet R Vallieres E et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer N Engl J Med 2005, 352:2589-2597. 10.1056/NEJMoa043623 15972865
3. Arriagada R Bergman B Dunant A Le Chevalier T Pignon JP Vansteenkiste J Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 2004, 350:351-360. 10.1056/NEJMoa031644 14736927
4. Kato H Ichinose Y Ohta M Hata E Tsubota N Tada H Watanabe Y Wada H Tsuboi M Hamajima N Ohta M A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung N Engl J Med 2004, 350:1713-1721. 10.1056/NEJMoa032792 15102997
5. Moss TJ Sanders DG Detection of neuroblastoma cells in blood J Clin Oncol 1990, 8:736-740. 2179482
6. Gross HJ Verwer B Houck D Hoffman RA Recktenwald D Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7) Proc Natl Acad Sci USA 1995, 92:537-541. 42776 7831325 10.1073/pnas.92.2.537
7. Peck K Sher YP Shih JY Roffler SR Wu CW Yang PC Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients Cancer Res 1998, 58:2761-2765. 9661888
8. Ge M Shi D Wu Q Wang M Li L Fluctuation of circulating tumor cells in patients with lung cancer by real-time fluorescent quantitative-PCR approach before and after radiotherapy J Cancer Res Ther 2005, 1:221-226. 17998657
9. Burger JA Kipps TJ CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment Blood 2006, 107:1761-1767. 10.1182/ blood-2005-08-3182 16269611
10. Rollins BJ Chemokines Blood 1997, 90:909-928. 9242519
11. Baggiolini M Dewald B Moser B Human chemokines: An update Annu Rev Immunol 1997, 15:675-705. 10.1146/annurev.immunol.15.1.675 9143704
12. Luster AD Chemokines-chemotactic cytokines that mediate inflammation N Engl J Med 1998, 338:436-445. 10.1056/NEJM199802123380706 9459648
13. Kakinuma T Hwang ST Chemokines, chemokine receptors, and cancer metastasis J Leukoc Biol 2006, 79:639-651. 10.1189/jlb.1105633 16478915
14. Zlotnik A Yoshie O Chemokines: A new classification system and their role in immunity Immunity 2000, 12:121-127. 10.1016/ S1074-7613(00)80165-X 10714678
15. Balkwill F Cancer and the chemokine network Nat Rev Cancer 2004, 4:540-550. 10.1038/nrc1388 15229479
16. Muller A Homey B Soto H Ge N Catron D Buchanan ME McClanahan T Murphy E Yuan W Wagner SN et al. Involvement of chemokine receptors in breast cancer metastasis Nature 2001, 410:50-56. 10.1038/35065016 11242036
17. Balkwill F The significance of cancer cell expression of the chemokine receptor CXCR4 Semin Cancer Biol 2004, 14:171-179. 10.1016/ j.semcancer.2003.10.003 15246052
18. Kucia M Jankowski K Reca R Wysoczynski M Bandura L Allendorf DJ Zhang J Ratajczak J Ratajczak MZ CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion J Mol Histol 2004, 35:233-245. 10.1023/ B:HIJO.0000032355.66152.b8 15339043
19. Zlotnik A Chemokines in neoplastic progression Semin Cancer Biol 2004, 14:181-185. 10.1016/j.semcancer.2003.10.004 15246053
20. Phillips RJ Burdick MD Lutz M Belperio JA Keane MP Strieter RM The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases Am J Respir Crit Care Med 2003, 167:1676-1686. 10.1164/rccm.200301-071OC 12626353
21. Moepps B Braun M Knopfle K Dillinger K Knochel W Gierschik P Characterization of a Xenopus laevis CXC chemokine receptor 4: implications for hematopoietic cell development in the vertebrate embryo Eur J Immunol 2000, 30:2924-2934. 10.1002/ 1521-4141(200010)30:10<2924::AID-IMMU2924>3.0.CO;2-Y 11069075
22. Ma Q Jones D Springer TA The chemokine receptor CXCR4 is required for the retention of B lineage and granulocytic precursors within the bone marrow microenvironment Immunity 1999, 10:463-471. 10.1016/ S1074-7613(00)80046-1 10229189
23. Kucia M Reca R Miekus K Wanzeck J Wojakowski W Janowska-Wieczorek A Ratajczak J Ratajczak MZ Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: Pivotal role of the SDF-1-CXCR4 axis Stem Cells 2005, 23:879-894. 10.1634/ stemcells.2004-0342 15888687
24. Phillips RJ Burdick MD Hong K Lutz MA Murray LA Xue YY Belperio JA Keane MP Strieter RM Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis J Clin Invest 2004, 114:438-446. 484979 15286810
25. Strieter RM Chemokines: Not just leukocyte chemoattractants in the promotion of cancer Nat Immunol 2001, 2:285-286. 10.1038/86286 11276195
26. Phillips RJ Mestas J Gharaee-Kermani M Burdick MD Sica A Belperio JA Keane MP Strieter RM Epidermal growth factor and hypoxia-induced expression of CXC chemokine receptor 4 on non-small cell lung cancer cells is regulated by the phosphatidylinositol 3-kinase/PTEN/AKT/ mammalian target of rapamycin signaling pathway and activation of hypoxia inducible factor-1alpha J Biol Chem 2005, 280:22473-22481. 10.1074/jbc.M500963200 15802268
27. Holland JD Kochetkova M Akekawatchai C Dottore M Lopez A McColl SR Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells Cancer Res 2006, 66:4117-4124. 10.1158/0008-5472.CAN-05-1631 16618732
28. Su L Zhang J Xu H Wang Y Chu Y Liu R Xiong S Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells Clin Cancer Res 2005, 11:8273-8280. 10.1158/ 1078-0432.CCR-05-0537 16322285
29. Yoon Y Liang Z Zhang X Choe M Zhu A Cho HT Shin DM Goodman MM Chen ZG Shim H CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models Cancer Res 2007, 67:7518-7524. 10.1158/0008-5472.CAN-06-2263 17671223
30. Pan J Mestas J Burdick MD Phillips RJ Thomas GV Reckamp K Belperio JA Strieter RM Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis Mol Cancer 2006, 5:56. 1636662 17083723 10.1186/1476-4598-5-56
31. Kimura S Hara Y Pineau T Fernandez-Salguero P Fox CH Ward JM Gonzalez FJ The T/ebp null mouse: Thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary Genes Dev 1996, 10:60-69. 10.1101/gad.10.1.60 8557195
32. Anagnostou VK Syrigos KN Bepler G Homer RJ Rimm DL Thyroid transcription factor 1 is an independent prognostic factor for patients with stage I lung adenocarcinoma J Clin Oncol 2009, 27:271-278. 10.1200/ JCO.2008.17.0043 19064983
33. Sawabata N Okumura M Utsumi T Inoue M Shiono H Minami M Nishida T Sawa Y Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: Pilot study using an immunocytology method Gen Thorac Cardiovasc Surg 2007, 55:189-192. 10.1007/s11748-007-0101-2 17554991
34. Kubuschok B Passlick B Izbicki JR Thetter O Pantel K Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer J Clin Oncol 1999, 17:19-24. 10458213
35. Zhu ZH Sun BY Ma Y Shao JY Long H Zhang X Fu JH Zhang LJ Su XD Wu QL Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer J Clin Oncol 2009, 27:1091-1099. 10.1200/JCO.2008.16.6991 19188679
36. Nagrath S Sequist LV Maheswaran S Bell DW Irimia D Ulkus L Smith MR Kwak EL Digumarthy S Muzikansky A Isolation of rare circulating tumour cells in cancer patients by microchip technology Nature 2007, 450:1235-1239. 10.1038/nature06385 18097410
37. Schioppa T Uranchimeg B Saccani A Biswas SK Doni A Rapisarda A Bernasconi S Saccani S Nebuloni M Vago L Regulation of the chemokine receptor CXCR4 by hypoxia Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL J Exp Med 2003, 198:1391-1402. 2194248 14597738 10.1084/jem.20030267
38. Staller P Sulitkova J Lisztwan J Moch H Oakeley EJ Krek W Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL Nature 2003, 425:307-311. 10.1038/nature01874 13679920
39. Pantuck AJ Zeng G Belldegrun AS Figlin RA Pathobiology, prognosis, and targeted therapy for renal cell carcinoma: Exploiting the hypoxia-induced pathway Clin Cancer Res 2003, 9:4641-4652. 14581333
40. Liu YL Yu JM Song XR Wang XW Xing LG Gao BB Regulation of the chemokine receptor CXCR4 and metastasis by hypoxia-inducible factor in non small cell lung cancer cell lines Cancer Biol Ther 2006, 5:1320-1326. 16929169
41. Ceradini DJ Kulkarni AR Callaghan MJ Tepper OM Bastidas N Kleinman ME Capla JM Galiano RD Levine JP Gurtner GC Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 Nat Med 2004, 10:858-864. 10.1038/nm1075 15235597
42. Schioppa T Uranchimeg B Saccani A Biswas SK Doni A Rapisarda A Bernasconi S Saccani S Nebuloni M Vago L Regulation of the chemokine receptor CXCR4 by hypoxia J Exp Med 2003, 198:1391-1402. 2194248 14597738 10.1084/jem.20030267
43. Zagzag D Krishnamachary B Yee H Okuyama H Chiriboga L Ali MA Melamed J Semenza GL Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: Von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor Cancer Res 2005, 65:6178-6188. 10.1158/0008-5472.CAN-04-4406 16024619
44. Hudes G Carducci M Tomczak P Dutcher J Figlin R Kapoor A Staroslawska E Sosman J McDermott D Bodrogi I Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma N Engl J Med 2007, 356:2271-2281. 10.1056/NEJMoa066838 17538086
45. Shepherd FA Rodrigues Pereira J Ciuleanu T Tan EH Hirsh V Thongprasert S Campos D Maoleekoonpiroj S Smylie M Martins R Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 2005, 353:123-132. 10.1056/NEJMoa050753 16014882
46. Granville CA Warfel N Tsurutani J Hollander MC Robertson M Fox SD Veenstra TD Issaq HJ Linnoila RI Dennis PA Identification of a highly effective rapamycin schedule that markedly reduces the size, multiplicity, and phenotypic progression of tobacco carcinogen-induced murine lung tumors Clin Cancer Res 2007, 13:2281-2289. 10.1158/ 1078-0432.CCR-06-2570 17404113